An Authoritative Update on ABT-199 for CLL - CLL Support
An Authoritative Update on ABT-199 for CLL
You need to be a member of this community to see this post.
24 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
ABT-199 Trial experience in Australia
Following are my notes on the presentation by Andrew Roberts, to the Australian Leukaemia...
Venetoclax(ABT-199)/rituximab achieved an Overall Rate of Response of 88%
ASH2014 - Clinical Care Options (free to join) capsule update on...
Venetoclax (ABT-199)Plus...
ABT-199 plus Obinutuzimab
Finally remembered my login! Just a quick note to let you know I started the trial today at Barts...
ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL
Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...
ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...
Related Posts
- ASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)
- My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
- ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.
- Ibrutinib Use in the Real World for CLL
Update on my participation in an ABT199 clinical trial
